Joel Isaacson & Co’s CYTOMEDIX INC COM NEW GTF Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2014
Q4
Sell
-10,000
Closed -$4K 691
2014
Q3
$4K Hold
10,000
﹤0.01% 547
2014
Q2
$4K Hold
10,000
﹤0.01% 522
2014
Q1
$5K Buy
+10,000
New +$5K ﹤0.01% 504

Joel Isaacson & Co's GTF Position: Q4 2014 in Review

Joel Isaacson & Co sold out of CYTOMEDIX INC COM NEW (GTF) in Q4 2014, closing a stake of 10,000 shares — an estimated $4K sold.

Joel Isaacson & Co first reported a position in GTF in Q1 2014 and held it in 3 quarters. The position peaked at $5K in Q1 2014. 0 funds tracked by Wall St. Rank hold GTF as of Q4 2014.

  • Joel Isaacson & Co reported no remaining CYTOMEDIX INC COM NEW position as of Q4 2014 after selling out during the quarter.
  • Joel Isaacson & Co sold 10,000 CYTOMEDIX INC COM NEW shares in Q4 2014, an estimated $4K.
  • Joel Isaacson & Co first reported a position in CYTOMEDIX INC COM NEW in Q1 2014 and held it in 3 quarters.
  • Joel Isaacson & Co's CYTOMEDIX INC COM NEW position peaked at $5K in Q1 2014.
  • 0 funds tracked by Wall St. Rank held CYTOMEDIX INC COM NEW as of Q4 2014.

Based on Joel Isaacson & Co's 13F filing for Q4 2014, filed 9 Jan 2015.